Potential mechanisms for failure to eradicate group A streptococci from the pharynx

Pediatrics

Volumn 104, Issue 4 I, 1999, Pages 911-917

  Gerber, Michael A ^a,f   Tanz, Robert R ^b   Kabat, William ^c   Bell, Gillian L ^a   Siddiqui, Parveen N ^c   Lerer, Trudy J ^a   Lepow, Martha L ^d   Kaplan, Edward L ^e   Shulman, Stanford T ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Group A streptococci; Pharyngitis; Streptococcus pyogenes; Treatment

Indexed keywords

CEFADROXIL; PENICILLIN V;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RATE; MAJOR CLINICAL STUDY; PHARYNGITIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; TREATMENT FAILURE; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ANALYSIS OF VARIANCE; ANTIBIOSIS; BETA-LACTAMASES; CARRIER STATE; CEFADROXIL; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; HUMANS; PENICILLIN V; PENICILLINS; PHARYNGITIS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TREATMENT FAILURE;

EID: 0032826494     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.104.4.911     Document Type: Article

References (40)

1. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever. Pediatrics. 1995;26:758-764
2. American Academy of Pediatrics, Committee on Infectious Diseases. 1997 Red Book. Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997
3. Gastanaduy AS, Kaplan EL, Huwe BB, McKay C, Wannamaker LW. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet. 1980;2:498-502
4. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med. 1981;98:326-335
5. Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal pharyngitis: is the difference worth it? Pediatr Infect Dis J. 1993;12:258-274
6. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J. 1991;10:275-281
7. Gerber MA. Treatment failures and carriers: perception or problem? Pediatr Infect Dis J. 1994;13:576-579
8. Macris MH, Hartman N, Murray B, et al. Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatr Infect Dis J. 1998;17:377-381
9. Gerber MA. Antibiotic resistance in group A streptococci. Pediatr Clin North Am. 1995;42:539-551
10. Kim KS, Kaplan EL. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr. 1985;107:681-684
11. Smith TD, Huskins WC, Kim KS, Kaplan EL. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr. 1987;110:777-782
12. Crowe DD, Sanders WE Jr, Longley S. Bacterial interference. II Role of the normal throat flora in prevention of colonization of group A streptococcus. J Infect Dis. 1973;128:527-532
13. Roos K, Grahn E, Holm SE. Evaluation of beta-lactamase activity and microbiology interference in treatment failures of acute streptococcal tonsillitis. Scan J Infect Dis. 1986;18:313-319
14. Huskins WC, Kaplan EL. Inhibitory substances produced by Streptococcus salivarius and colonization of the upper respiratory tract with group A streptococci. Epidemiol Infect. 1989;102:401-412
15. Tanz RR, Shulman ST, Sroka PA, Marubio S, Brook I, Yogev R. Lack of influence of beta-lactamase producing flora on recovery of group A streptococci after treatment of acute pharyngitis. J Pediatr. 1990;117: 859-863
16. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med. 1981;98:326-335
17. Shulman ST, Gerber MA, Tanz RR, Markowitz M. Streptococcal pharyngitis: the case for penicillin therapy. Pediatr Infect Dis J. 1994;13: 1-7
18. Gerber MA, Randolph MF, Chanatry J, Wright LL, Anderson LR, Kaplan EL. Once daily therapy for streptococcal pharyngitis with cefadroxil. J Pediatr. 1986;109:531-537
19. O'Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of beta-lactamase by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972;1:283-288
20. Rosen IG, Jacobson J, Rudderman R. Rapid capillary tube method for detecting penicillin resistance in staphylococcus aureus. Appl Microbial. 1972;23:649-650
21. Markowitz M, Gordis L. Mail in technique for detecting penicillin in urine: application to the study of maintenance of prophylaxis in rheumatic fever patients. Pediatrics. 1968;41:151-153
22. Johnson DR, Kaplan EL, Srarmek J, et al. Laboratory Diagnosis of Group A Streptococcal Infections. Geneva, Switzerland: World Health Organization; 1996
23. Kaplan EL. The group A streptococcal upper respiratory tract carrier state: an enigma. J Pediatr. 1980;97:337-345
24. Kaplan EL, Top FH Jr, Dudding BA, Wannamaker LW. Diagnosis of streptococcal pharyngitis: differentiation of acute infection from the carrier state in the symptomatic child. J Infect Dis. 1971;123:490-501
25. Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child. 1972;124:352-358
26. Shulman ST. Streptococcal pharyngitis: clinical and epidemiologic factors. Pediatr Infect Dis J. 1989;8:816-819
27. Markowitz M, Gerber MA, Kaplan EL. Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature. J Pediatr. 1993;123:679-685
28. Gerber MA, Randolph MF, DeMeo K, Feder HM, Kaplan EL. Failure of once-daily penicillin V therapy for streptococcal pharyngitis. Am J Dis Child. 1989;143:153-155
29. Pichichero ME, McLinn SE, Gooch WM, et al. Ceftibutin vs. Penicillin V in group A beta-hemolytic streptococcal pharyngitis. Pediatr Infect Dis J. 1995;14:S102-S107
30. Block SL, Hedrick JA, Tyler RD. Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Dis J. 1992;11:919-925
31. Govan JRW. In vivo significance of bacteriocins and bacteriocin receptors. Scand J Infect Dis. 1986;49:31-37
32. Sanders CC, Sanders WE Jr, Harrowe DJ. Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci. Infect Immunol. 1976;13:808-812
33. Brook I, Gober AE. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg. 1995; 121:1405-1409
34. Simon HJ, Sakain W. Staphylococcal antagonism to penicillin G therapy of hemolytic streptococcal pharyngeal infection: effect of oxacillin. Pediatrics. 1963;31:463-469
35. Quie PG, Pierce HC, Wannamaker LW. Influence of penicillinase producing staphylococci on the eradication of group A streptococci from the upper respiratory tract by penicillin treatment. Pediatrics. 1966;37: 467-476
36. Markowitz M, Kramer I, Goldstein E. Persistence of group A streptococci as related to penicillinase-producing staphylococci: comparison of penicillin V potassium and sodium nafcillin. J Pediatr. 1967;71:132-137
37. Brook I. The role of beta-lactamase producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984;6:601-607
38. Brook I. Role of anaerobic beta-lactamase producing bacteria in upper respiratory tract infections. Pediatr Infect Dis J. 1987;6:310-316
39. Reilly S, Timmis P, Beeden AG, Willis AT. Possible role of the anaerobe in tonsillitis. J Clin Pathol. 1981;34:542-547
40. Dykhuizen RS, Golder D, Reid TM, Gould IM. Phenoxymethyl penicillin versus co-amoxiclav in the treatment of acute streptococcal pharyngitis, and the role of beta-lactamase activity in saliva. J Antimicrob Chemother. 1996;37:133-138